Jeffrey A. Ploetz's Page

About this author: - Seeking Alpha (blog)

About this author: Seeking Alpha (blog) The remainder of this letter explores the federal stimulus options and the health care bill just passed in the House. Most of us at some time or another ... Stock market skyrocketing above 10000 but a falling dollar still a problem

Health Scare Tactics - RealClearPolitics (blog)

Los Angeles Times

Health Scare Tactics RealClearPolitics (blog) No rational person believes the stimulus "caused" unemployment to rise. I mean the flood of sheer factual misstatements about the health care bill. ... Falling Far Short of Reform Pelosi barely passes health care bill; Reid's woes worsen in Nevada Representatives' votes on health reform bill  - -

Los Angeles to use $10.3 million in stimulus funds for worker-training programs - Los Angeles Times

Los Angeles to use $10.3 million in stimulus funds for worker-training programs Los Angeles Times City will offer $4 million for vocational training for 1000 workers and keep $6.3 million available for 2000 people in healthcare, construction, ...

September 2009 OnBioVC | Trend Analysis Now Available

Hot off the press! The September 2009 OnBioVC | Trend Analysis study is now available for download [HERE]. Over $465M flowed into early-stage biopharma, diagnostic and device companies in the ninth month of 2009 and over $4,806M year-to-date! If you find the information in OnBioVC to be of value kindly forward on to colleagues who [...]

Celladon, Inc.: Series C $21.8M

Celladon (La Jolla, CA) a clinical-stage company focused on gene therapy for congestive heart failure, closed a $21.8M Series C financing. Participants include Enterprise Partners Venture Capital, Venrock and Johnson & Johnson Dev Corp.

Quanta Fluid Solutions, Ltd.: Series A $14.3M

Quanta Fluid Solutions (United Kingdom) a development-stage medical device company focused on haemodialysis systems for acute renal failure, has closed a $14.3M Series A financing. Participants include NBGI Ventures, Seroba Kernel Life Sciences, Wellington Partners Venture Capital and Brains-To-Ventures.

Calypso Medical Technologies, Inc.: Series E $50M

Calypso Medical Technologies (Seattle, WA) a commercial-stage medical device company focused on implantable sensor electromagnetic transponders, to accurately and continuously pinpoint the location of tumors in real-time during radiation therapy delivery, closed a $50M Series E financing. Participants include Skyline Ventures, Frazier Healthcare Ventures, Bay City Capital and InterWest Partners.

NextBio, Inc.: Series C $8M

NextBio (Cupertino, CA) a commercial-stage bioinformatics and competitive intelligence bioscience search engine, closed a $8M Series C financing. Participants include Newbury Ventures.